Keybanc Maintains Overweight on Doximity, Lowers Price Target to $30

Benzinga Newsdesk www.benzinga.com Negative 75.7%

Neg 75.7% Neu 0% Pos 0%

Keybanc analyst Brandon Nispel maintains Doximity (NYSE:DOCS) with a Overweight and lowers the price target from $38 to $30.